Biologics APIs

Apr 19, 2018
By Pharmaceutical Technology Editors
The agency has granted breakthrough therapy designation to Roche’s hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.
Apr 19, 2018
By Pharmaceutical Technology Editors
Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.
Apr 17, 2018
By Pharmaceutical Technology Editors
Industry experts will discuss lyophilization best practices and continuous manufacturing for biopharmaceuticals.
Apr 12, 2018
By Pharmaceutical Technology Editors
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
Apr 11, 2018
By Pharmaceutical Technology Editors
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.
Apr 10, 2018
By Pharmaceutical Technology Editors
The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.
Apr 09, 2018
By Pharmaceutical Technology Editors
Celltrion received complete response letters from FDA for its rituximab and trastuzumab biosimilars.
Apr 09, 2018
By Pharmaceutical Technology Editors
Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.
Apr 09, 2018
By Pharmaceutical Technology Editors
Roche has acquired a program to develop regenerative therapies for multiple sclerosis.
Apr 06, 2018
By Pharmaceutical Technology Editors
Boehringer Ingelheim and OSE Immunotherapeutics have entered a global immuno-oncology partnership to develop a checkpoint inhibitor for treating advanced solid tumors.
native1_300x100
lorem ipsum